BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  BioSpace Announces 2024 Best Places to Work in Biopharma Winners

  BioSpace, the leader in biopharma news and careers has published its 2024 Best Places to Work list.

  November 7, 2023

   · 

  2 min read
• Genetown

  Sosei Heptares’ President & CEO and Head of UK R&D to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2023

  Sosei Group Corporation announces its President & CEO, Chris Cargill, and Matt Barnes, Head of UK R&D, will participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference on Tuesday, 14 November at 10:30 a.m. GMT / 5:30 a.m. ET / 7:30 p.m. JST.

  November 7, 2023

   · 

  3 min read
• Biotech Bay

  Epic Bio to Participate in Upcoming November 2023 Investor Conference

  Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, announced that the management will participate in an upcoming investor conference.

  November 7, 2023

   · 

  1 min read
• BioMed X Launches a New Call for Application in Autoimmune Disease Research

  BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.

  November 7, 2023

   · 

  2 min read
• Business

  Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023

  Affimed N.V. announced that it will release third quarter 2023 results and corporate update on Tuesday, November 14, 2023.

  November 7, 2023

   · 

  1 min read
• Business

  Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

  Sage Therapeutics, Inc. reported business highlights and financial results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  21 min read
• Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

  Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development.

  November 7, 2023

   · 

  4 min read
• Business

  Update relating to LEQEMBI® from Eisai’s investor presentation of their quarterly report published today

  BioArctic AB’s partner Eisai held a presentation on the second quarter of Eisai’s fiscal year, ending March 2024.

  November 7, 2023

   · 

  6 min read
• Business

  BrainStorm to Announce Third Quarter 2023 Financial Results and Provide a Corporate Update

  BrainStorm Cell Therapeutics Inc. announced that it will hold a conference call on Tuesday, November 14th at 8:30 a.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2023 and provide a corporate update.

  November 7, 2023

   · 

  4 min read
• Business

  Amneal Reports Third Quarter 2023 Financial Results

  Amneal Pharmaceuticals, Inc. announced its results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  30 min read